1 not yet recruiting, 1 recruiting, 1 unknown. 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Bin Du: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| mGFR vs tGFR in AKI transdermal GFR - AKI, GFR | Phase 4 | Not yet recruiting | Bin Du | 50 | 2026-06-08 | 2026-06-10 |
| Corticosteroids in Hyperinflammatory Phenotype of Critical Illness Methylprednisolone (MP), Placebo - Sepsis, Acute Respiratory Distress Syndrome | Phase 2 | Recruiting | Bin Du | 150 | 2026-04-15 | 2026-05-26 |
| Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP caspofungin, TMP/SMZ(trimethoprim/sulfisoxazole), Methylprednisolone - Pneumocystis Pneumonia | Phase 4 | Unknown | Bin Du | 122 | 2019-08-14 | 2019-09-12 |
Acute Kidney Injury (1) · Pneumonia, Pneumocystis (1) · Respiratory Distress Syndrome (1) · Sepsis (1)
Methylprednisolone (2) · Caspofungin (1) · Sulfisoxazole (1)
China (2)
PMID 11505124, PMID 24004539, PMID 29194145, PMID 34518032, PMID 38964736, PMID 39918882, PMID 41726007